paper
present
case
communityacquir
necrotis
pneumonia
due
pantonvalentin
leukocidineposit
methicillinsuscept
staphylococcu
aureu
influenzaviru
coinfect
woman
despit
presenc
pejor
prognost
factor
clinic
cours
patient
favour
background
paper
present
case
communityacquir
necrotis
pneumonia
due
pantonvalentin
leukocidineposit
methicillinsuscept
staphylococcu
aureu
influenzaviru
coinfect
woman
despit
presenc
pejor
prognost
factor
clinic
cours
patient
favour
staphylococcu
aureu
respons
communityacquir
pneumonia
aureu
pneumonia
often
characteris
rapidli
progress
extens
bilater
pneumonia
defin
necrotis
pneumonia
pantonvalentin
leukocidin
pvl
one
mani
toxin
produc
aureu
target
leucocyt
necrotis
pneumonia
associ
product
pvl
presenc
pvl
aureu
associ
primari
skin
infect
necrotis
pneumonia
young
immunocompet
patient
frequent
associ
fatal
outcom
report
communityacquir
necrotis
pneumonia
due
pvlposit
methicillinesuscept
aureu
influenzaviru
coinfect
young
adult
woman
favour
outcom
novemb
woman
admit
intens
care
unit
icu
acut
respiratori
failur
free
chronic
diseas
made
journey
mecca
eighth
day
journey
patient
suffer
cough
fever
fatigu
purul
sputum
nurs
autoprescrib
amoxyclavulan
although
prescript
need
physician
order
two
day
return
franc
hospitalis
icu
sever
dyspnoea
associ
left
thorac
pain
nasal
swab
perform
admiss
patient
posit
pandem
influenzaviru
realis
use
xpert
flu
assay
cepheid
tabl
next
day
bronchoalveolar
lavag
bal
perform
bacteriolog
virolog
mycolog
parasitolog
analysi
seeplex
pcr
assay
seegen
posit
influenzaviru
exclud
viral
coinfect
bacteriolog
result
microscop
examin
bal
reveal
presenc
gramposit
cocci
polymorphonuclear
neutrophilsml
without
epitheli
cell
h
incub
quantit
cultur
yield
monobacteri
speci
aureu
cfuml
bal
identifi
matrixassist
laser
desorpt
ionis
timeofflight
mass
spectrometri
malditof
ms
use
thin
smear
strain
maldipl
vitro
antimicrobi
suscept
test
strain
obtain
use
vitek
system
marci
letoil
franc
strain
resist
penicillin
g
tetracyclin
two
test
detect
methicillinoresist
neg
cefoxitin
screen
oxacillin
minimum
inhibitori
concentr
mgl
meca
gene
detect
pcr
strain
use
primer
describ
unal
et
al
strain
associ
sequenc
type
st
use
previous
describ
method
state
patient
wors
thorac
therapeut
drug
monitor
show
necrosi
suspicion
pvl
evoc
methicillinsuscept
aureu
strain
detect
pvl
posit
realtim
pcr
rtpcr
describ
previous
deurenberg
et
al
bal
test
detect
adenoviru
influenzaviru
parainfluenzaviru
respiratori
syncyti
viru
metapneumoviru
herp
simplex
viru
varicellazona
viru
cytomegaloviru
use
direct
immunofluoresc
assay
ultra
dfa
respiratori
viru
screen
identif
kit
diagnost
hybrid
usa
neg
tabl
bal
inocul
monolay
human
fibroblast
vero
bgm
cell
viral
cultur
neg
patient
return
mecca
new
human
merscov
suspect
detect
upe
region
coronaviru
genom
rtpcr
bal
nasal
swab
neg
microscop
examin
giemsa
ortho
toluidin
blue
stain
bal
cultur
bal
chromogen
medium
chromagar
sabouraud
medium
antibiot
reveal
mycolog
element
aspergillu
antigen
portion
detect
genom
pneumocysti
jirovecii
aspergillu
fumigatusflavu
neg
acidfast
bacilli
shown
direct
examin
bal
mycobacterium
tuberculosi
neg
week
incub
six
blood
cultur
set
aerob
anaerob
bottl
bact
alert
biomerieux
marci
letoil
franc
drawn
admiss
patient
neg
oseltamivir
prescrib
day
detect
pvl
toxin
initi
empir
antimicrobi
therapi
switch
oxacillin
month
clindamycin
day
antitoxin
effect
left
lung
present
larg
destruct
necrosi
multipl
abscess
pleuriti
thorac
surgeri
partial
lung
resect
pleurostomi
perform
day
difficult
wean
mechan
ventil
two
ventilatoracquir
pneumonia
patient
discharg
icu
day
total
hospit
length
stay
day
pvlposit
aureu
pneumonia
rare
gener
adult
popul
especi
western
european
countri
aetiolog
often
consid
delay
physician
case
share
mani
featur
communityacquir
pvlposit
aureu
pneumonia
describ
previou
studi
inde
form
pneumonia
affect
preferenti
young
immunocompet
healthi
individu
haemoptysi
common
find
associ
acut
respiratori
distress
syndrom
frequent
previous
describ
predict
factor
fatal
outcom
regard
biolog
data
leucopenia
thrombopenia
frequent
observ
initi
stage
diseas
white
cell
count
l
observ
wherea
previou
studi
demonstr
sever
leucopoenia
anoth
predict
factor
fatal
outcom
mortal
rate
associ
white
cell
count
case
present
found
origin
pvlposit
aureu
strain
respons
communityacquir
pneumonia
abl
find
healthi
carrier
aureu
strain
environ
patient
patient
return
work
time
hospitalis
origin
pvlposit
aureu
strain
seem
communityacquir
inde
carriag
pvlposit
aureu
strain
among
rel
patient
necrotis
pneumonia
describ
literatur
recent
carriag
pvlposit
aureu
strain
describ
either
popul
adult
popul
preschool
children
aureu
strain
associ
st
infrequ
found
europ
pvlposit
aureu
colonis
popul
may
play
key
role
epidemiolog
communityassoci
infect
pvlposit
aureu
case
report
influenzaviru
initi
detect
nasal
swab
use
rapid
pcr
test
confirm
second
time
bal
sampl
pvlposit
aureu
communityacquir
pneumonia
influenzalik
syndrom
often
describ
day
prior
onset
necrotis
pneumonia
detect
influenzaviru
rare
report
associ
pvlposit
methicillinresist
aureu
b
influenzavirus
previous
report
knowledg
first
report
pvlposit
methicillinsuscept
aureu
influenzaviru
coinfect
immunocompet
adult
influenzaviru
case
present
detect
pvl
associ
favour
outcom
pvlposit
aureu
necrotis
pneumonia
often
associ
high
death
rate
associ
pvl
virul
remain
controversi
inde
sever
studi
describ
pvl
independ
indic
virul
author
attribut
virul
aureu
isol
entir
genotyp
data
suggest
pvl
contribut
aureu
pathogenesi
import
pvl
virul
must
elucid
healthi
young
immunocompet
adult
present
necrotis
pneumonia
leucopoenia
thombopenia
influenzaviru
infect
pantonvalentin
leukocidin
pvl
posit
staphylococcu
aureu
coinfect
consid
particular
collabor
physician
microbiologist
quickli
detect
strain
pvlposit
aureu
best
treatment
promot
favour
outcom
patient
regard
mortal
rate
associ
diseas
treatment
option
clindamycin
antitoxin
effect
chosen
physician
relev
